Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Most people who search for where to get a GLP-1 are really asking about a category of medicines, not a single pen. This PlexusDx Education Hub guide treats the receptor-agonist class as one connected system — the hormone, the engineered drugs, the labels, and the genetics that sit above all of them. Browse all Peptides & GLP-1 education
"Where to get GLP-1" is a class-level question rather than a brand-level one. To answer it well, it helps to separate four things: the hormone itself, the pharmacology that turns it into a therapy, the specific compounds that carry the label, and the safety terrain they all share. Legitimate access always runs through a licensed prescriber who matches a product to its FDA-approved indication.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
The hormone before the medicine
Glucagon-like peptide-1 is an incretin hormone released by enteroendocrine L-cells in the small intestine after you eat. It prompts glucose-dependent insulin secretion from pancreatic beta cells, quiets glucagon output from alpha cells, slows how fast the stomach empties, and signals fullness in the hypothalamus. On its own it lasts only minutes, because the enzyme DPP-4 clears it from circulation almost immediately.
Turning a short-lived signal into a drug
A GLP-1 receptor agonist is a peptide — or, in newer cases, a small molecule — that binds the GLP-1 receptor while resisting DPP-4, stretching its working life from minutes into hours or days. That extension lets it reproduce native GLP-1 biology at a pharmacological dose: insulin release, glucagon suppression, delayed gastric emptying, and appetite reduction through central satiety. Tirzepatide goes a step further, engaging the GIP receptor as well and adding a second incretin arm.
The compounds that carry the label
As of April 2026 the FDA-approved GLP-1 receptor agonists include exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), lixisenatide (historically; discontinued in the U.S.), and semaglutide (Ozempic, Wegovy, Rybelsus). Tirzepatide (Mounjaro, Zepbound) is the GIP/GLP-1 dual agonist. The investigational triple agonist retatrutide (GLP-1 / GIP / glucagon) has Phase 3 data but is not approved, and oral non-peptide agonists such as orforglipron remain in late-stage development.
How access maps to the FDA label
Indications differ by compound and product: type 2 diabetes (most products), chronic weight management (Wegovy, Saxenda, Zepbound), cardiovascular risk reduction in type 2 diabetes (Ozempic, Trulicity, Victoza, Rybelsus), and obstructive sleep apnea in adults with obesity (Zepbound, December 2024). Certain products also carry pediatric indications. The label governs which product a clinician can prescribe for which purpose — that mapping, not a website, is the gatekeeper to legitimate access.
The safety terrain the class shares
Every FDA-approved GLP-1 receptor agonist and the GIP/GLP-1 dual agonist carry the class boxed warning for thyroid C-cell tumor risk seen in rodent studies. A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is a contraindication. Gastrointestinal effects — nausea, vomiting, diarrhea, constipation — are the most common and cluster around dose escalation. Serious events reported in use include pancreatitis, gallbladder problems, and acute kidney injury when dehydration is present.
The genetic layer above every GLP-1 decision
Variants in FTO, GLP1R, MC4R, and TCF7L2 help set baseline GLP-1 signaling, appetite regulation, and energy balance. They are pathway-level: they do not predict how you will respond to any single compound, but they do describe the biology every GLP-1 medicine acts on. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting any protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including those FTO, MC4R, and TCF7L2 variants — so the biology enters the conversation with your provider instead of guesswork. That is the test before you invest approach.
Related reading on PlexusDx: What Is GLP-1?, GLP-1 Receptor Agonist, GLP-1 Drugs, GLP-1 Hormone.
Disclaimer: This article is educational. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use them. PlexusDx does not sell, prescribe, or recommend any other therapeutic peptide in the GLP-1 category beyond semaglutide and tirzepatide (including dulaglutide, liraglutide, retatrutide, cagrilintide, and related compounds). The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Start with the biology. Take the Precision Peptide Genetic Test, or explore the Weight Management Protocols.
Frequently Asked Questions
What exactly is a GLP-1 receptor agonist?
It is a peptide or emerging small molecule that binds the GLP-1 receptor and resists rapid DPP-4 breakdown, so it can drive insulin release, slow gastric emptying, and cue satiety at a therapeutic level. Approved examples include semaglutide, liraglutide, dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide.
How do single-receptor and dual-receptor agonists differ?
A GLP-1 receptor agonist engages only the GLP-1 receptor, while the GIP/GLP-1 dual agonist tirzepatide adds the GIP receptor. Clinical programs such as SURPASS and SURMOUNT suggest the dual mechanism can produce larger average effects on weight and glucose in some trial populations, though individual results vary.
Does the Precision Peptide Genetic Test tell me which GLP-1 to take?
No. It does not predict response to any compound in the class. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology — the upstream context that applies across every receptor agonist and the dual agonist alike.
Who should not take a GLP-1 medicine?
Anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is contraindicated under every label in the class. People with a history of pancreatitis or significant gastrointestinal disease need careful review. Discuss your full history with a provider.
Keep exploring the class in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where to Get Ozempic: Prescription Rules and Telehealth Steps
Where to Get Ozempic: Prescription Rules and Telehealth Steps